BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2488563)

  • 1. Bromocriptine treatment of cyclical mastalgia/fibrocystic breast disease: update on the European trial.
    Dogliotti L; Mansel RE
    Br J Clin Pract Suppl; 1989 Nov; 68():26-32; discussion 49-53. PubMed ID: 2488563
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled trial of the prolactin inhibitor bromocriptine (Parlodel) in the treatment of severe cyclical mastalgia.
    Nazli K; Syed S; Mahmood MR; Ansari F
    Br J Clin Pract; 1989 Sep; 43(9):322-7. PubMed ID: 2695151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine.
    Murta EF; de Freitas MM; Velludo MA
    Rev Paul Med; 1992; 110(6):251-6. PubMed ID: 1341021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrocystic breast disease.
    Scott EB
    Am Fam Physician; 1987 Oct; 36(4):119-26. PubMed ID: 3314435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European multicentre trial of bromocriptine in cyclical mastalgia.
    Mansel RE; Dogliotti L
    Lancet; 1990 Jan; 335(8683):190-3. PubMed ID: 1967667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
    Mussa A; Sandrucci S; Dogliotti L
    Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bromocriptine in fibro-cystic mastopathy].
    Marzetti L; Framarino ML; Dei Malatesta ML; Aragona C; De Angelis R
    Riv Ital Ginecol; 1980; 59(4-5):357-64. PubMed ID: 7313397
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanisms and effects of bromocriptine in the treatment of breast hyperplasia].
    Gao SQ
    Zhonghua Wai Ke Za Zhi; 1988 Dec; 26(12):733-5, 781-2. PubMed ID: 3248468
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of chronic treatment with bromocriptine in patients with fibrocystic mastopathy].
    Ablanedo J; Canales ES
    Arch Invest Med (Mex); 1988; 19(3):225-9. PubMed ID: 3242433
    [No Abstract]   [Full Text] [Related]  

  • 10. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease.
    Mansel RE; Preece PE; Hughes LE
    Br J Surg; 1978 Oct; 65(10):724-7. PubMed ID: 361149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment].
    van Bogaert LJ
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclical mastalgia and breast pathology.
    Jørgensen J; Watt-Boolsen S
    Acta Chir Scand; 1985; 151(4):319-21. PubMed ID: 4041107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of fibrocystic mastopathy with bromocriptine].
    López Rosales C; Castellanos Rodríguez J; García Carmona MR
    Ginecol Obstet Mex; 1985 Aug; 53():233-6. PubMed ID: 3908225
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum prolactin and oestradiol levels in women with cyclical mastalgia.
    Watt-Boolsen S; Andersen AN; Blichert-Toft M
    Horm Metab Res; 1981 Dec; 13(12):700-2. PubMed ID: 7319468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised controlled trial of medroxyprogesterone acetate in mastalgia.
    Maddox PR; Harrison BJ; Horobin JM; Walker K; Mansel RE; Preece PE; Nicholson RI
    Ann R Coll Surg Engl; 1990 Mar; 72(2):71-6. PubMed ID: 2139769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastalgia.
    Preece PE
    Practitioner; 1982 Aug; 226(1370):1373-82. PubMed ID: 7134151
    [No Abstract]   [Full Text] [Related]  

  • 17. Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study.
    Aydin Y; Atis A; Kaleli S; Uludağ S; Goker N
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):203-6. PubMed ID: 20206430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain.
    Hinton CP; Bishop HM; Holliday HW; Doyle PJ; Blamey RW
    Br J Clin Pract; 1986 Aug; 40(8):326-30. PubMed ID: 3527249
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrocystic disease of breast. Clinico-therapeutic considerations].
    Favia G; Lumachi F; D'Amico C; De Battisti S; Annunziata N; Berto M
    Minerva Chir; 1988 May; 43(9):759-62. PubMed ID: 3173746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.